Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like MACD crossed over, could be a good week ahead if it holds.
Conclusion:
Utilizing ActiPatch® as a chronic pain therapy treatment improves patient quality of life, while reducing the
economic burden to the NHS.
It's funny how this board is so quiet yet the volume is a good quantity. Where is the interest originating from?
.108 to .119 all moves should be like this.
Other than Timothy are any of these guys still involved?
Robert S. Sand (CEO)
Yakubov Ruben(President)
Terry Lee Harris (Other)
Timothy Barham (Vice President and Secretary)
Let her rip! MACD showed it's going North two weeks ago. Let her widen the gap significantly on the way up.
Or you could have put it into a Roth IRA and waited 5 years so you aren't paying taxes on the profit. Taxes are payed up front when you buy it. Any appreciation after that is TAX FREE!
An upward trend is the answer! LOL
What are we missing here?
Yes, ZERO in taxes!!! You need to look into a ROTH IRA when you're young. You pay the taxes up front on the original purchase price. The catch is you have to wait/hold for five years before you can sell without paying capital gains. All my QTMM stock is now tax free from capital gains and it is finally ready to run. Zero tax on millions, brings a smile to my face.
Want to transfer a million or two into my account? LOL
Isn't it strange that this starts heading north after the five year lockup expires? There's more to that story we don't know. Go FBEC time to run north.
February 19, 2016
FBEC Worldwide, Inc. entered into a 5 Year Lock-up Agreement with MIDAM Ventures LLC. Pursuant to the Lock-up Agreement, MIDAM will act as the exclusive provider to the Company of the following services: (i) investor relations and public relations, (ii) product marketing; (iii) product development; (iv) day to day business advice; (v) assistance in writing and submission of all press releases and public filings; (vi) fund raising; (vii) optimizing corporate structure: (viii) bookkeeping; and (ix) vendor relations. SOURCE
Feb. 22, 2016
FBEC Worldwide, Inc. a beverage company with intellectual property formulas and marketing capability for the production and distribution of proprietary beverages and CBD products, is pleased to announce 100,000,000 common shares will be retired and an additional 50,000,000 common shares will be restricted to a 5 year lockup agreement.
Midam Ventures LLC has executed a stock purchase agreement with former CEO Robert Sand in which Midam purchased 150,000,000 common shares from Robert Sand. The Company has been informed by Midam that they will be retiring 100,000,000 shares back to the Company's Treasury immediately. In addition, the Company and Midam have agreed to a 5 year lockup agreement for the remaining 50,000,000 shares effective today until February 22, 2021.
Midam's managing partner Adam Heimann stated, "Given both my and Midam's involvement with FBEC Worldwide, we felt it beneficial to the Company's future to clean up the existing share structure. Removing such a large equity position from previous management creates a healthier environment for both current and future shareholders."
Mr. Heimann added, "FBEC Worldwide is a company of great promise. In a short period of time, new management has grown a robust product portfolio, brought product to market, formed strategic joint ventures, and added celebrity endorsement. Midam's decision to retire 100,000,000 shares and agree to a lock up agreement for the remaining 50,000,000 shares, was based on our confidence in the long term growth potential of the Company."
CEO Jason Spatafora said, "The confidence that Midam Ventures has demonstrated today is a testament to the growth potential for FBEC Worldwide & to a greater extent the industry as a whole. The capital structure has greatly improved today and FBEC has a team committed to its future for the next five years. I couldn't be more excited about the positive impact this will have on FBEC's future." SOURCE
QMC HealthID Provides COVID Testing Support For Victoires De La Musique Awards Ceremony
QMC HealthID™ used to assist in pre-event COVID testing at the prestigious Les Victoires de la Musique annual awards ceremony for the French music industry.
April 15, 2021 09:15 AM Eastern Daylight Time
PARIS--(BUSINESS WIRE)--QMC HealthID, a wholly owned subsidiary of Quantum Materials Corp, announced that it had deployed its QMC HealthID™ software platform to assist with voluntary COVID testing at Les Victoires de la Musique music industry awards ceremony held February 12th in Paris, France.
“QMC was honored to play a part in the COVID prevention plans for the Les Victoires de la Musique awards ceremony”
Tweet this
Held yearly since 1985, Les Victoires de la Musique is an annual French award ceremony delivered by the French Ministry of Culture that recognizes outstanding achievement in the music industry and the best musical artists of the year.
In conjunction with test manufacturer Innova Medical Group, a COVID-19 screening area was set up to voluntarily administer the Innova SARS-CoV-2 Antigen Rapid Qualitative Test. During the pre-event screening process, the QMC HealthID™ mobile application platform enabled medical staff to verify participants, assess their test result outcome, and then notify the participants of their test outcomes.
“By supporting this major national cultural event, QMC HealthID and Innova allowed the media and the participants to experience a simple and viable solution to make the awards ceremony safer against COVID-19,” said Xavier Guerin, President of EMEA of Innova Medical Group.
The production of the Victoires De La Musique Ceremony requires approximately 400 technicians and journalists in addition to the musicians themselves. QMC and Innova coordinated on pre-event COVID-19 testing to demonstrate that the event production company was taking appropriate precautions to protect the health of the musicians as well as journalists and all event production staff.
“QMC was honored to play a part in the COVID prevention plans for the Les Victoires de la Musique awards ceremony,” said Stephen B. Squires, CEO of Quantum Materials Corp. “Helping make the awards ceremony safer to attend in person is 100% in line with our mission of getting people back to work quickly and safely.”
About Quantum Materials Corp
At Quantum Materials our scientists and engineers believe in the power of innovation to make life better and solve critical problems facing our world. Whether its applied research into quantum materials, the development of advanced digital platforms, or creating new tools for personal health, we find our inspiration in discovering new solutions to build a better future for all. Quantum Materials is pioneering unique solutions in the area of quantum dot fabrication, quantum tagging, digital trust systems, and most recently, in the development of QMC HealthID™. Our team comprises experts in the areas of quantum materials, nanotechnology, health diagnostics, therapeutic health, digital platforms, advanced logistics, and anti-counterfeiting. As a company, we believe in collaboration. We find that innovation begins with the spark of a new insight that is rigorously pursued in a collegial and interdisciplinary environment. Bringing breakthrough ideas to life and forging new solutions inspires our work. For more information, visit Quantum Materials Corp at www.quantummaterialscorp.com
About QMC HealthID Inc.
QMC HealthID Inc., a wholly owned subsidiary of Quantum Materials Corp. (OTC Bulletin Board: QTMM), leverages its QMC technologies to address global health challenges spurred by current and future pandemics. The QMC HealthID management platform and mobile app authenticates the process of infectious disease testing and gives the individual control over the data they share and their personal health status. Virtually any current COVID-19 point of care or laboratory-based diagnostic test, including Innova Medical Group’s, SARS-CoV-2 Antigen Rapid Qualitative Test, can be implemented in the QMC HealthID™ testing and reporting solution. These tests along with the mobile app are designed to test for COVID-19, with benefit towards helping people get safely and securely back to work, school, travel, events and living. For more information, please visit www.qmchealthid.com.
QMC HealthID™, Forward-Looking Statements
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans” and similar expressions. Although QMC HealthID’s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of QMC HealthID™, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the fact that product candidates if approved may not be commercially successful, the future approval and commercial success of therapeutic alternatives, QMC HealthID’s ability to benefit from external growth opportunities, to complete related transactions and/or obtain regulatory clearances, risks associated with intellectual property and any related pending or future litigation and the ultimate outcome of such litigation, trends in exchange rates and prevailing interest rates, volatile economic and market conditions, cost containment initiatives and subsequent changes thereto, and the impact that COVID-19 will have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. Any material effect of COVID-19 on any of the foregoing could also adversely impact us. This situation is changing rapidly, and additional impacts may arise of which we are not currently aware and may exacerbate other previously identified risks. Other than as required by applicable law, QMC HealthID™ does not undertake any obligation to update or revise any forward-looking information or statements.
?
Contacts
Nikki Franklin
W2O
nfranklin@w2ogroup.com
?
QMC HEALTHID INC.
OTCBB:QTMM ? ?
More News?
March 17, 2021
QMC HealthID Partners with PopupRx; Deploys HealthID Solution Within Pharmacies Across Texas
March 03, 2021
Quantum Materials Corp Expands Executive Leadership Team To Execute Growth Strategy
February 23, 2021
QMC HealthID Partners with Tried & Tested to Support COVID-19 Diagnostic Testing in the UK
Log In
Sign Up
More from Business Wire
Blog
UK/Ireland
Deutschland
France
Hong Kong
Italy
Japan
Tradeshownews.com
Contact Us
UK Tax Strategy
Privacy
Manage Cookies
Terms of Use
© 2021 Business Wire, Inc.
You can't go by the closed market bid and ask prices displayed. They are pretty meaningless as a predictor for the next market open.
Headed north of .023, settled at .0235, looking good. New ask is . 0294.
I hope they can grow as fast as the market and keep up with demand. Apparently it's going to be an interesting couple months ahead.
https://alchemycreativeco.com/ is the site address.
It is not http://www.alchemycreativeinc.com as shown on other sites and for those not having the intro displayed here.
But that won't be for months, correct?
Up up and away!
Bought my first million. Now it can go and get high. lol ??????
Has any Conoco crude oil found in the article ever flowed out of those areas and to the refineries?
You are correct, it is Binaxnow not Innova's test. They are only selling the test. QMC HealthID could still be used for recording results. If results are good for 2-3 days it would save needless testing each day.
It will work well in colleges, and probably OK in highschool but not in the lower grades. Kids in elementary schools and middle school aren't too good at holding on to expensive phones.
Fully understand, the 8k's may give a little more insight. Just keep your eyes on it.
Look into QTMM - Quantum Materials Corp. they are setting up to be a Unicorn status company (over $1 billion) with there Coronavirus mitigation platform - QMC HealthID Inc, anti-counterfeiting and solar cells printed as fast as newspaper. At 9 cents and in the process of uplisting to NASDAQ you will be HAPBEE to have found this company too.
How many opportunities passed by waiting for that one day. However, if we didn't do what we did the company wouldn't be where it is today. I think it's time we get a nice return for our patience and support. Let her rip north...... it's well over due!
Somewhat like what CBULF was QTMM plans to go NASDAQ from their current 9 cents. Something to look into. Sorry I missed this one.
On January 26, 2021, Quantum Materials Corp. (the “Company”) and Pasaca Capital Inc. (“Pasaca”) entered into a Securities Purchase and Financing Agreement (the “Purchase Agreement”). Pursuant to the terms of the Purchase Agreement, at the first closing, Pasaca will convert three previously issued promissory notes made by the Company payable to Pasaca and loan to the Company an additional $1,500,000 pursuant to a certain Secured Convertible Promissory Note (the “Convertible Note”) made by the Company payable to Pasaca in the principal amount of $4,500,000 (the “Senior Note”). The Senior Note is convertible into 154,228,625 shares of the Company’s common stock (the “Note Shares”). At the second closing, Pasaca will purchase common stock of the Company (“Common Stock”) in an amount such that, after such purchase and the conversion of the Senior Note into the Note Shares, Pasaca will own fifty-one percent (51.0%) of the fully diluted common stock of the Company. The purchase price for the Common Stock to be sold in the second closing is $10,500,000. Pasaca will also have the right to appoint three members to the Company’s Board of Directors. Both the first and second closing are subject to numerous contingencies, as set forth in the Purchase Agreement.
Financials just went from RED to BLACK!!!
Will be a good day to watch the price movement as word gets around.
I don't think it was intentional or miss leading by management but you never know, https://www.globenewswire.com/news-release/2020/12/04/2139812/0/en/Sona-Nanotech-Inc-Investors-Company-Investigated-by-the-Portnoy-Law-Firm.html
In the mean time look at a 3 center in the covid mix that makes Quantum Dots. QTMM
Yes he did, he was the primary person responsible in the lab at that time and thought batch was better.
That is a GREAT PR!
A wild ass guess to your question would be YES. "Just a hypothetical, but I wonder if these locations may have potential partnerships with QMC's health ID?" Why else would they include those specific sites. Now if they can get New York on board that would be huge, but I'm happy they have California and a bunch of the southern states where it's flaring up.
I don't think it is so minor. It shows USA and the United Kingdom. The US site HAS 20 locations displayed and the UK has one still in Beta testing: https://coronavirus.data.gov.uk/#category=nations&map=rate&area=e92000001
That completion time may be realistic if they can get the exterior completed so the interior is closed in. Then the monsoon season won't have much of an effect on interior work unless flooding becomes an issue. My take away from their response is money for completion of the project is not in jeopardy Let's hope they can keep to the revised schedule.
Sorry to hear that but I know some Canadians that own the stock. I'm not sure who their broker was/is at the time they purchased but it wasn't in their Roth/TFSA account either.
Put some of that profit when you take a little off the shelf into QTMM - Quantum Materials Corp. @ 2 cents a share. They are doing the QDX HealthID mitigation process of "back to work safely" during this Coronavirus pandemic. That's on top of the rest of their diversified Quantum Dot use portfolio in Solar, Anti-counterfeiting, medical, TV's / displays of all types and Lighting.
TD Ameritrade filled my order today.
Here is a link to the audio for the presentation:
https://healthcarethinktank.org/online-conference-with-quantum-materials/
=====> QTMM CORONAVIRUS UPDATE <=====
Quantum Materials Corp. - TODAY there are TWO webinars where you can get more updated info:
SIGN UP FOR Jay Williams NEXT ONLINE EVENT VIA ZOOM:
https://my.healthcarethinktank.org/event-3826845
MAY 6th, 2020 STARTING AT 2PM - 3PM
Steve Squires Austin Inno webinar to aid the fight against Covid-19 starts MAY 6th at 4pm EDT "Pivots and Paths Forward for Austin Startups"
https://register.gotowebinar.com/register/5085060265467192847?mc_cid=145ee8899c&mc_eid=2fcfa345de&fbclid=IwAR11OmaTc8z5mE2hdtQDvy-OCD2ktc_CeaAzG5b0pTBIXpVnkWjRiqEbUoo
WHAT IS IT ABOUT?
The beauty of the QDX HealthID is all the TEST RESULTS are then tracked with visible results shown with their ID that they are SAFE to re-enter the work force, Tested but under quarantine, Taken the test and waiting for results.
All the other companies are trying to identify if you are a carrier of the disease or are trying to develop a vaccine. No one is tracking and documenting testing and the results. This program will aid the medical research programs tracking and monitoring the efficacy of different drugs in combating the virus. Until there is an immunization developed companies will have to protect their students and work force with this type of tracking program developed by Quantum Materials Corp.
Steve Squires and Les Paull talk at 2 minute mark on Coronavirus update by KVUE(abc) TV Texas on mitigation program for BACK TO WORK SAFELY. The program is HIPAA compliant, a $2 fee is covered by the testing program and QMC "is in talks with state and federal leaders".
http://www.kvue.com/video/news/health/coronavirus/coronavirus-san-marcos-company-covid19-test-verification-technology/269-98f146cc-aac6-456e-b955-f0e0fd15b624?jwsource=cl
________________________________________________________________
Quantum Materials Corp - QTMM
https://www.quantummaterialscorp.com/
=====> QTMM CORONAVIRUS UPDATE <=====
Quantum Materials Corp. - Tomorrow there are TWO webinars where you can get more updated info:
SIGN UP FOR Jay Williams NEXT ONLINE EVENT VIA ZOOM:
https://my.healthcarethinktank.org/event-3826845
MAY 6th, 2020 STARTING AT 2PM - 3PM
Steve Squires Austin Inno webinar to aid the fight against Covid-19 starts MAY 6th at 4pm EDT "Pivots and Paths Forward for Austin Startups"
https://register.gotowebinar.com/register/5085060265467192847?mc_cid=145ee8899c&mc_eid=2fcfa345de&fbclid=IwAR11OmaTc8z5mE2hdtQDvy-OCD2ktc_CeaAzG5b0pTBIXpVnkWjRiqEbUoo
WHAT IS IT ABOUT?
The beauty of the QDX HealthID is all the TEST RESULTS are then tracked with visible results shown with their ID that they are SAFE to re-enter the work force, Tested but under quarantine, Taken the test and waiting for results.
All the other companies are trying to identify if you are a carrier of the disease or are trying to develop a vaccine. No one is tracking and documenting testing and the results. This program will aid the medical research programs tracking and monitoring the efficacy of different drugs in combating the virus. Until there is an immunization developed companies will have to protect their students and work force with this type of tracking program developed by Quantum Materials Corp.
Steve Squires and Les Paull talk at 2 minute mark on Coronavirus update by KVUE(abc) TV Texas on mitigation program for BACK TO WORK SAFELY. The program is HIPAA compliant, a $2 fee is covered by the testing program and QMC "is in talks with state and federal leaders".
http://www.kvue.com/video/news/health/coronavirus/coronavirus-san-marcos-company-covid19-test-verification-technology/269-98f146cc-aac6-456e-b955-f0e0fd15b624?jwsource=cl
________________________________________________________________
Quantum Materials Corp - QTMM
https://www.quantummaterialscorp.com/
How SAVVY are you? Enough to see the potential?
=====> QTMM CORONAVIRUS UPDATE <=====
Tomorrow there are TWO webinars where you can get more updated info:
SIGN UP FOR Jay Williams NEXT ONLINE EVENT VIA ZOOM:
https://my.healthcarethinktank.org/event-3826845
MAY 6th, 2020 STARTING AT 2PM - 3PM
Steve Squires Austin Inno webinar to aid the fight against Covid-19 starts MAY 6th at 4pm EDT "Pivots and Paths Forward for Austin Startups"
https://register.gotowebinar.com/register/5085060265467192847?mc_cid=145ee8899c&mc_eid=2fcfa345de&fbclid=IwAR11OmaTc8z5mE2hdtQDvy-OCD2ktc_CeaAzG5b0pTBIXpVnkWjRiqEbUoo
WHAT IS IT ABOUT?
The beauty of the QDX HealthID is all the TEST RESULTS are then tracked with visible results shown with their ID that they are SAFE to re-enter the work force, Tested but under quarantine, Taken the test and waiting for results.
All the other companies are trying to identify if you are a carrier of the disease or are trying to develop a vaccine. No one is tracking and documenting testing and the results. This program will aid the medical research programs tracking and monitoring the efficacy of different drugs in combating the virus. Until there is an immunization developed companies will have to protect their students and work force with this type of tracking program developed by Quantum Materials Corp.
Steve Squires and Les Paull talk at 2 minute mark on Coronavirus update by KVUE(abc) TV Texas on mitigation program for BACK TO WORK SAFELY. The program is HIPAA compliant, a $2 fee is covered by the testing program and QMC "is in talks with state and federal leaders".
http://www.kvue.com/video/news/health/coronavirus/coronavirus-san-marcos-company-covid19-test-verification-technology/269-98f146cc-aac6-456e-b955-f0e0fd15b624?jwsource=cl
________________________________________________________________
Quantum Materials Corp - QTMM
https://www.quantummaterialscorp.com/
________________________________________________________________